Outlook Therapeutics, Inc. SC 13D and SC 13D/A reports

Location
111 S. Wood Avenue, Unit #100, Iselin, New Jersey
State of incorporation
Delaware
Fiscal year end
September 30
Data updated at
5/29/2024, 01:30 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Apr 17, 2024
SC 13D/A Report UNDER THE SECURITIES EXCHANGE ACT OF 1934 Mar 20, 2024
SC 13D/A Report SC 13D/A Jan 31, 2024
SC 13D/A Report SC 13D/A Nov 29, 2023
SC 13D/A Report AMENDMENT NO. 1 Dec 29, 2022
SC 13D/A Report SC 13D/A Jul 8, 2022
SC 13D Report SCHEDULE 13D Jul 7, 2022
SC 13D/A Report AMENDMENT NO. 16 Apr 22, 2022
SC 13D/A Report AMENDMENT NO. 15 Feb 1, 2022
SC 13D/A Report AMENDMENT NO. 14 Dec 1, 2021
SC 13D/A Report SC 13D/A Feb 5, 2021
SC 13D/A Report AMENDMENT NO. 13 Feb 2, 2021
SC 13D Report SCHEDULE 13D Jun 12, 2020
SC 13D/A Report AMENDMENT NO. 12 Mar 24, 2020
SC 13D/A Report AMENDMENT NO. 11 Feb 27, 2020
SC 13D/A Report SC 13D/A Jan 31, 2020
SC 13D/A Report SC 13D/A Dec 30, 2019
SC 13D/A Report SC 13D/A Jun 19, 2019
SC 13D/A Report SC 13D/A Apr 17, 2019
SC 13D/A Report SC 13D/A Feb 5, 2019
SC 13D/A Report SC 13D/A Jan 3, 2019
SC 13D/A Report AMENDMENT NO. 4 TO SCHEDULE 13D Nov 9, 2018
SC 13D/A Report AMENDMENT NO. 3 Jul 20, 2018
SC 13D/A Report AMENDMENT NO. 2 Jun 25, 2018
SC 13D/A Report AMENDMENT NO. 1 Nov 1, 2017
SC 13D Report SCHEDULE 13D Sep 18, 2017